UBS has cleared a critical hurdle in its complex integration of Credit Suisse, confirming the successful migration of the former rival’s global client base. However, the bank’s shares face immediate pressure from looming regulatory decisions that could impose significant new capital requirements.
Operational Milestone Achieved
The bank announced on March 18 that the worldwide transfer of former Credit Suisse clients onto UBS systems is complete. CEO Sergio Ermotti confirmed the migration of approximately 1.2 million accounts globally. With this phase concluded, the legacy IT infrastructure from Credit Suisse is scheduled for decommissioning by the end of March. The full dismantling of the former platform is projected to continue through the end of 2026.
Financially, the integration continues to yield projected benefits. Cumulative savings attributed to the merger are expected to rise from their current level of $10.7 billion to approximately $13.5 billion by the conclusion of 2026. The bank reported a net profit of $7.8 billion for 2025, with total assets under management now exceeding $7 trillion.
Should investors sell immediately? Or is it worth buying UBS?
Share Performance and Regulatory Headwinds
Despite these operational advances, UBS equity has struggled in the market. The stock is trading nearly 20% below its January peak of 41.10 euros, reflecting investor apprehension. A primary concern is an impending regulatory review by the Swiss government, set for April, which will determine stricter capital rules for systemically important banks. Analysts estimate these changes could necessitate UBS holding up to an additional $26 billion in capital. Such a requirement would likely increase funding costs and constrain the bank’s financial agility.
Shareholder Meeting on the Horizon
Attention now turns to the bank’s Annual General Meeting, scheduled for April 15. Key agenda items include the allocation of profits and a proposed dividend distribution of $1.10 per share for the 2025 fiscal year. Shareholder sentiment regarding the capital question will be a significant factor influencing the bank’s narrative this spring, as the market weighs solid integration progress against the potential drag of heightened regulatory demands.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from March 20 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 20.
UBS: Buy or sell? Read more here...
